Abstract:The development of therapeutic interventions for diseases necessitates a crucial step known as drug screening, wherein potential substances with medicinal properties are rigorously evaluated. This process has undergone a transformative evolution, driven by the imperative need for more efficient, rapid, and high-throughput screening platforms. Among these, microfluidic systems have emerged as the epitome of efficiency, enabling the screening of drug candidates with unprecedented speed and minimal sample consumption. This review paper explores the cutting-edge landscape of microfluidic-based drug screening platforms, with a specific emphasis on two pioneering approaches: organ-on-a-chip and C. elegans-based chips. Organ-on-a-chip technology harnesses human-derived cells to recreate the physiological functions of human organs, offering an invaluable tool for assessing drug efficacy and toxicity. In parallel, C. elegans-based chips, boasting up to 60% genetic homology with humans and a remarkable affinity for microfluidic systems, have proven to be robust models for drug screening. Our comprehensive review endeavors to provide readers with a profound understanding of the fundamental principles, advantages, and challenges associated with these innovative drug screening platforms. We delve into the latest breakthroughs and practical applications in this burgeoning field, illuminating the pivotal role these platforms play in expediting drug discovery and development. Furthermore, we engage in a forward-looking discussion to delineate the future directions and untapped potential inherent in these transformative technologies. Through this review, we aim to contribute to the collective knowledge base in the realm of drug screening, providing valuable insights to researchers, clinicians, and stakeholders alike. We invite readers to embark on a journey into the realm of microfluidic-based drug screening platforms, fostering a deeper appreciation for their significance and promising avenues yet to be explored.

On-chip Sub-cellular Resolution Whole-animal Manipulation for High-throughput in Vivo Screening

Microengineering Methods for Cell-Based Microarrays and High-Throughput Drug-Screening Applications

Microfluidics in High-Throughput Drug Screening: Organ-on-a-Chip and C. elegans-Based Innovations

Ultrahigh-Throughput Enzyme Engineering and Discovery in In Vitro Compartments

Combining Scalable Organ Chip Platform with Deep Learning-Based Imaging Analysis for Cancer Therapeutic Screening

High-throughput screening of biomolecules using cell-free gene expression systems

Fish Capsules: A System for High‐Throughput Screening of Combinatorial Drugs

Microfluidics-enabled phenotyping, imaging, and screening of multicellular organisms

Droplet microfluidic technology for single-cell high-throughput screening

Development of an automated 3D high content cell screening platform for organoid phenotyping

High-throughput cellular microarray platforms: applications in drug discovery, toxicology and stem cell research

Stand-Sit Microchip for High-Throughput, Multiplexed Analysis of Single Cancer Cells

Body-on-a-chip: Microfluidic based futuristic approach for Drug Screening

State-of-the-art in high throughput organ-on-chip for biotechnology and pharmaceuticals

From Chips-in-Lab to Point-of-Care Live Cell Device: Development of a Microfluidic Device for On-Site Cell Culture and High-Throughput Drug Screening

A high-throughput, open-space and reusable microfluidic chip for combinational drug screening on tumor spheroids

Fishing on Chips: Up-And-Coming Technological Advances in Analysis of Zebrafish and Xenopus Embryos

Organs-on-chips at the frontiers of drug discovery

In vivo functional screening for systems-level integrative cancer genomics

Emerging Trends in Organ-on-a-chip Systems for Drug Screening

High content drug screening of primary cardiomyocytes based on microfluidics and real-time ultra-large-scale high-resolution imaging